A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS

Thumbnail Image

Files

Kahts_Proof_2024.pdf (800.65 KB)

Date

2024-11

Authors

Kahts, Maryke
Mellet, Juanita
Durandt, Chrisna
Moodley, Kinosha
Summers, Beverley
Ebenhan, Thomas
Zeevaart, Jan Rijn
Aras, Omer
Pepper, Michael Sean

Journal Title

Journal ISSN

Volume Title

Publisher

SpringerOpen

Abstract

Please read abstract in article.

Description

DATA AVAILABITY STATEMENT: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Keywords

Mesenchymal stem cells (MSCs), Hematopoietic stem and progenitor cells (HSPCs), Cell labelling, In vivo cell tracking, Zirconium-89, SDG-03: Good health and well-being, SDG-09: Industry, innovation and infrastructure, Positron emission tomography (PET)

Sustainable Development Goals

SDG-03:Good heatlh and well-being
SDG-09: Industry, innovation and infrastructure

Citation

Kahts, M., Mellet, J., Durandt, C., Moodley, K., Summers, B., Ebenhan, T., Zeevaart, J.R., Aras, O. & Pepper, M.S. A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS. EJNMMI Radiopharmacy and Chemistry 2024 Nov 29; 9(1): 82. doi: 10.1186/s41181-024-00311-w.

URI

http://hdl.handle.net/2263/100807

Collections

Research Articles (Immunology)
Research Articles (University of Pretoria)
Full item page